HIMS Amazon is starting to sell cheap hair-loss drugs. BofA downgraded the stock from Buy to Underperform. The stock reacted with a 25% drop.I had always been concerned about the threat from Amazon, along with legal and regulatory issues for this stock.
I don't think Amazon will stop at just selling hair-loss drugs. They might go for everything that Hims offers and more.
As for the technicals, today's drop is a huge blow to the momentum. If you are bullish on the company, I would wait for the bottoming process.
At a minimum, it could check back to the uptrend line.
See the potential drop area in the chart.
As always, I share my opinions and trades. I'm not suggesting that anyone follow my trades. You do you.
I am not a licensed professional. None of the posts that I published are investment advice. Do your own research.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
I am not a licensed professional. None of the posts that I published are investment advice. Do your own research.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.